An update on IgG4-related lung disease

Area of Science:

• Immunology
• Pulmonology
• Rheumatology

Background:

• Immunoglobulin G4-related disease (IgG4-RD) is a systemic autoimmune condition.
• Lung involvement in IgG4-RD manifests as various inflammatory conditions, including inflammatory pseudotumor and interstitial pneumonitis.
• Accurate diagnosis of IgG4-related lung disease (IgG4-RLD) is complicated by the absence of specific diagnostic tests and the need to differentiate from mimicking conditions.

Purpose of the Study:

• To review current diagnostic algorithms for IgG4-related lung disease (IgG4-RLD).
• To discuss the potential role of biomarkers in the future diagnosis of IgG4-RLD.
• To provide an overview of the clinical presentation and management of IgG4-RLD.

Main Methods:

• Literature review of diagnostic strategies for IgG4-RLD.
• Analysis of current treatment recommendations for IgG4-RD.
• Exploration of emerging research on biomarkers for IgG4-related conditions.

Main Results:

• Current diagnosis relies on excluding other diseases and characteristic findings, lacking a definitive test.
• Corticosteroids, potentially combined with disease-modifying anti-rheumatic drugs, are the primary treatment.
• The long-term prognosis for IgG4-RLD is not yet well-established.

Conclusions:

• Diagnostic challenges persist for IgG4-RLD, necessitating further research into reliable biomarkers.
• Understanding diagnostic algorithms is crucial for timely and accurate patient management.
• Future investigations should focus on identifying specific biomarkers to improve diagnostic accuracy and prognostic understanding of IgG4-RLD.